Krka

The SBI TOP benchmark index on the Ljubljana Stock Exchange lost nearly 16% in 2022, after having risen by almost 40% the year before, show figures released by the stock exchange operator Ljubljanska Borza.

All the big-cap stocks were down with drug maker Krka losing nearly a fifth of its value in a year, NLB bank down by 18%, and energy group Petrol losing 21%.

Novo Mesto/Otočec – Pharmaceutical group Krka posted a net profit of EUR 177.4 million for the first half of the year, up 11% on the back of sales that reached EUR 808.6 million, up 1% over the same period last year, CEO Jože Colarič said at the company’s annual general meeting in Otočec on Thursday.

Novo Mesto – The Novo Mesto-based pharmaceutical group Krka generated EUR 1.53 billion in revenue last year, up 3% compared to 2019, while net profit has been estimated at EUR 286.6 million, up 17% year-on-year, show the unaudited preliminary results released on Thursday.

Gažić noted that the considerable interest from investors despite worrying trends on the capital markets made the event satisfying.